Cargando…

Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL

The correlation between Heme oxygenase-1 (HO-1) and dominant-negative Ikaros isoform 6 (IK6) is unclear. Firstly, we detected that IK6 existed in 20 of 42 (47.6%) adult BCR-ABL1-positive B-lineage acute lymphoblastic leukemia (BCR-ABL1-positive B-ALL) by using reverse transcribed polymerase chain re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiaojing, Zou, Xingli, Wang, Ziming, Fang, Qin, Chen, Shuya, Huang, Jun, Zhe, Nana, Yu, Meisheng, Zhang, Yaming, Wang, Jishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288214/ https://www.ncbi.nlm.nih.gov/pubmed/27447561 http://dx.doi.org/10.18632/oncotarget.10725

Ejemplares similares

Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1(+) pre–B ALL
por: Schjerven, Hilde, et al.
Publicado: (2017)

Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo
por: Zhou, Zhen, et al.
Publicado: (2017)

In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells
por: WEI, SIXI, et al.
Publicado: (2015)

Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin
por: Simand, Célestine, et al.
Publicado: (2021)

Bcr-Abl: one kinase, two isoforms, two diseases
por: Reckel, Sina, et al.
Publicado: (2017)

The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
por: Singh, Vivek, et al.
Publicado: (2022)

Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021)

Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors
por: Amata, Emanuele, et al.
Publicado: (2017)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Targeting the PTP1B‐Bcr‐Abl1 interaction for the degradation of T315I mutant Bcr‐Abl1 in chronic myeloid leukemia
por: Elgehama, Ahmed, et al.
Publicado: (2022)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia
por: Hai, Abdul, et al.
Publicado: (2014)

Therapeutic Roles of Heme Oxygenase-1 in Metabolic Diseases: Curcumin and Resveratrol Analogues as Possible Inducers of Heme Oxygenase-1
por: Son, Yong, et al.
Publicado: (2013)

The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases
por: Yang, Qing, et al.
Publicado: (2022)

Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
por: Cavelier, Lucia, et al.
Publicado: (2015)

Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48
por: Zhang, Tianzhuo, et al.
Publicado: (2022)

Integrative Survival Response Evoked by Heme Oxygenase-1 and Heme Metabolites
por: Pae, Hyun-Ock, et al.
Publicado: (2008)

How Heme Oxygenase-1 Prevents Heme-Induced Cell Death
por: Lanceta, Lilibeth, et al.
Publicado: (2015)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
por: Araujo, Jesus A., et al.
Publicado: (2012)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Pharmacological Targeting of Heme Oxygenase-1 in Osteoarthritis
por: Sanada, Yohei, et al.
Publicado: (2021)

Pharmacological and Clinical Significance of Heme Oxygenase-1
por: Stec, David E., et al.
Publicado: (2021)

The roles of heme oxygenase-1 in renal disease
por: Zhai, Hongfu, et al.
Publicado: (2023)

Immune-Related Functions of Heme Oxygenase-1
por: Lianos, Elias A., et al.
Publicado: (2023)

Inflammation accelerates BCR-ABL1(+) B-ALL development through upregulation of AID
por: Zhang, Ping, et al.
Publicado: (2022)

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1(T315I) and BCR-ABL1(T315I-E255K)
por: Mian, Afsar Ali, et al.
Publicado: (2021)

Heatstroke Effect on Brain Heme Oxygenase-1 in Rats
por: Wen, Ya-Ting, et al.
Publicado: (2015)

Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
por: Kim, Jaeseung C., et al.
Publicado: (2023)

BCR‐ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK1 in ph(+) ALL
por: Cao, Wen‐bin, et al.
Publicado: (2018)

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
por: Zhou, Liang L., et al.
Publicado: (2008)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2022)

BCR-ABL1 transcript decline ratio combined BCR-ABL1(IS) as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia
por: Cai, Zhimei, et al.
Publicado: (2020)

Mechanisms of Resistance to the BCR-ABL1 Allosteric Inhibitor Asciminib
por: Qiang, Wang, et al.
Publicado: (2017)

Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis
por: Zhang, Zhaoyuan, et al.
Publicado: (2020)

Enzymological and structural characterization of Arabidopsis thaliana heme oxygenase‐1
por: Wang, Jia, et al.
Publicado: (2022)

A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
por: Montecchini, Oksana, et al.
Publicado: (2021)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
por: Maletzke, Saskia, et al.
Publicado: (2022)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1fjdvnpc7um18d1lqihbh04vh